|
11.11.2016 07:59:31
|
DGAP-News: BDI - BioEnergy International AG
DGAP-News: BDI - BioEnergy International AG: Sales increase in the third quarter of 2016 due to project progress as planned
(Grambach, November 11, 2016) The planned project progress of current orders as well as project completions ensure a successful third quarter of 2016.
BDI - BioEnergy International AG increased sales by 43.6% to a total of EUR 28.6 million due to the implementation and completion of various projects on schedule (9M 2015: EUR 19.9 million). The operating result improved accordingly year-on-year by EUR 3.3 million to EUR -0.1 million (9M 2015: EUR -3.4 million). The positive financial result including taxes led to a positive result for the period of EUR 1.4 million (9M 2015: EUR 0.7 million).
The prepayments already received in the previous year for the new commissions led to an above-average positive operating cash flow in 2015. As expected, these prepayments have decreased again because of material orders and project expenses, so that the operating cash flow with EUR -8.1 million is negative this year (9M 2015: EUR 3.5 million).
Sound equity position provides a good basis for the future
The equity ratio was 63.8% at the end of the third quarter of 2016 (December 31, 2015: 57.2%). Equity decreased by 0.8% to EUR 50.5 million (December 31, 2015: EUR 50.9 million). Together with the large portfolio of securities and the high level of liquid funds of EUR 48.3 million as at the balance sheet date (December 31, 2015: EUR 58.9 million), BDI is in a sound financial position.
Current project business
Two projects were handed over to customers successfully in the third quarter. One of them was a RetroFit project in California, while the other one was the high FFA esterification unit in Great Britain. Successful progress is being made with the second major project in Great Britain. The start-up of the brewer's grain fermentation plant for the Göss brewery has now been completed to a very large extent.
The development of the algae resource astaxanthin in the newly established BioLife Science business operations continues to be in an intensive research stage. Due to the need for more intensive development work, the start of construction of the industrial plant is being deferred until 2017. BDI is confident that it will be able to establish itself successfully in the booming life science market with this plant.
Planned Delisting
Following the reporting period BDI's principal shareholder, BDI Beteiligungs GmbH, announced to launch a voluntary offer for the shares held by the retail shareholders of BDI. The shareholders will be offered a price of EUR13.50 in exchange for each BDI share. BDI intends, in agreement with BDI Beteiligungs GmbH, to delist the shares of BDI from the Regulated Market of the Frankfurt Stock Exchange. BDI does not intend to initiate admission on any other regulated market or trading platform. The Management Board of BDI, after consultation of the Supervisory Board, welcomes the transaction as a whole and intends, subject to the review of the offer document, to support the offer and to recommend that BDI shareholders accept such offer. Further information on the delisting can be found in a corresponding Q & A on the website of BDI - BioEnergy International AG.
The interim statement about the 3rd quarter of 2016 can be downloaded via the following link:
Quarterly Results Q3 2016.pdf.
About BDI - BioEnergy International AG
BDI - BioEnergy International AG is market and technology leader in the construction of customized BioDiesel plants using the Multi-Feedstock Technology the company has developed itself, which can manufacture BioDiesel from different raw materials, such as Vegetable Oils, Used Cooking Oils and Animal Fats. In the "From Waste to Value" field BDI supplies efficient plant concepts that are designed to produce BioGas from industrial and municipal waste. Together with its subsidiary UIC GmbH BDI is also active in the field of vacuum distillation. UIC GmbH supplies equipment and components for the gentle distillation of liquid mixtures in both rough and fine vacuum. In the Life Science segment BDI creates with its fully-owned subsidiary BDI - BioLife Science GmbH new standards in the production of valuable algae-based products. This innovation enables the development of processes and equipment of the production and use of algae biomass.
BDI has specialised in the development of technologies that make optimum use of resources in the industrial processing of by- and waste products ever since it was established in 1996 and owns an extensive patent portfolio that has resulted from its in-house research and development activities. Our range of services includes public authority, basic and detailed engineering, installation and start-up as well as After-Sales support.
BDI - BioEnergy International AG and the companies it consolidates currently have 129 employees. The shares of BDI - BioEnergy International AG (ISIN AT0000A02177) are listed in the General Standard Market at the Frankfurt Stock Exchange.
Contact for further information:
Dr. Edgar Ahn Member of the Board, CSO BDI - BioEnergy International AG
Parkring 18 A-8074 Raaba-Grambach Tel: +43 (0) 316 4009 100 Fax: +43 0) 316 4009 110 www.bdi-bioenergy.com bdi@bdi-bioenergy.com
---------------------------------------------------------------------------
11.11.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English Company: BDI - BioEnergy International AG Parkring 18 A-8074 Grambach/Graz Austria Phone: +43 - 316 - 4009-100 Fax: +43 - 316 - 4009-110 E-mail: bdi@bdi-bioenergy.com Internet: www.bdi-bioenergy.com ISIN: AT0000A02177 WKN: A0LAXT Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart End of News DGAP News Service ---------------------------------------------------------------------------
519729 11.11.2016
DGAP-News: BDI - BioEnergy International AG / Key word(s): Quarterly /
Interim Statement
BDI - BioEnergy International AG: Sales increase in the third quarter of
2016 due to project progress as planned
11.11.2016 / 07:59
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Results for the 3rd quarter of 2016
BDI - BioEnergy International AG: Sales increase in the third quarter of
2016 due to project progress as planned
(Grambach, November 11, 2016) The planned project progress of current orders as well as project completions ensure a successful third quarter of 2016.
BDI - BioEnergy International AG increased sales by 43.6% to a total of EUR 28.6 million due to the implementation and completion of various projects on schedule (9M 2015: EUR 19.9 million). The operating result improved accordingly year-on-year by EUR 3.3 million to EUR -0.1 million (9M 2015: EUR -3.4 million). The positive financial result including taxes led to a positive result for the period of EUR 1.4 million (9M 2015: EUR 0.7 million).
The prepayments already received in the previous year for the new commissions led to an above-average positive operating cash flow in 2015. As expected, these prepayments have decreased again because of material orders and project expenses, so that the operating cash flow with EUR -8.1 million is negative this year (9M 2015: EUR 3.5 million).
Sound equity position provides a good basis for the future
The equity ratio was 63.8% at the end of the third quarter of 2016 (December 31, 2015: 57.2%). Equity decreased by 0.8% to EUR 50.5 million (December 31, 2015: EUR 50.9 million). Together with the large portfolio of securities and the high level of liquid funds of EUR 48.3 million as at the balance sheet date (December 31, 2015: EUR 58.9 million), BDI is in a sound financial position.
Current project business
Two projects were handed over to customers successfully in the third quarter. One of them was a RetroFit project in California, while the other one was the high FFA esterification unit in Great Britain. Successful progress is being made with the second major project in Great Britain. The start-up of the brewer's grain fermentation plant for the Göss brewery has now been completed to a very large extent.
The development of the algae resource astaxanthin in the newly established BioLife Science business operations continues to be in an intensive research stage. Due to the need for more intensive development work, the start of construction of the industrial plant is being deferred until 2017. BDI is confident that it will be able to establish itself successfully in the booming life science market with this plant.
Planned Delisting
Following the reporting period BDI's principal shareholder, BDI Beteiligungs GmbH, announced to launch a voluntary offer for the shares held by the retail shareholders of BDI. The shareholders will be offered a price of EUR13.50 in exchange for each BDI share. BDI intends, in agreement with BDI Beteiligungs GmbH, to delist the shares of BDI from the Regulated Market of the Frankfurt Stock Exchange. BDI does not intend to initiate admission on any other regulated market or trading platform. The Management Board of BDI, after consultation of the Supervisory Board, welcomes the transaction as a whole and intends, subject to the review of the offer document, to support the offer and to recommend that BDI shareholders accept such offer. Further information on the delisting can be found in a corresponding Q & A on the website of BDI - BioEnergy International AG.
The interim statement about the 3rd quarter of 2016 can be downloaded via the following link:
Quarterly Results Q3 2016.pdf.
About BDI - BioEnergy International AG
BDI - BioEnergy International AG is market and technology leader in the construction of customized BioDiesel plants using the Multi-Feedstock Technology the company has developed itself, which can manufacture BioDiesel from different raw materials, such as Vegetable Oils, Used Cooking Oils and Animal Fats. In the "From Waste to Value" field BDI supplies efficient plant concepts that are designed to produce BioGas from industrial and municipal waste. Together with its subsidiary UIC GmbH BDI is also active in the field of vacuum distillation. UIC GmbH supplies equipment and components for the gentle distillation of liquid mixtures in both rough and fine vacuum. In the Life Science segment BDI creates with its fully-owned subsidiary BDI - BioLife Science GmbH new standards in the production of valuable algae-based products. This innovation enables the development of processes and equipment of the production and use of algae biomass.
BDI has specialised in the development of technologies that make optimum use of resources in the industrial processing of by- and waste products ever since it was established in 1996 and owns an extensive patent portfolio that has resulted from its in-house research and development activities. Our range of services includes public authority, basic and detailed engineering, installation and start-up as well as After-Sales support.
BDI - BioEnergy International AG and the companies it consolidates currently have 129 employees. The shares of BDI - BioEnergy International AG (ISIN AT0000A02177) are listed in the General Standard Market at the Frankfurt Stock Exchange.
Contact for further information:
Dr. Edgar Ahn Member of the Board, CSO BDI - BioEnergy International AG
Parkring 18 A-8074 Raaba-Grambach Tel: +43 (0) 316 4009 100 Fax: +43 0) 316 4009 110 www.bdi-bioenergy.com bdi@bdi-bioenergy.com
---------------------------------------------------------------------------
11.11.2016 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de
---------------------------------------------------------------------------
Language: English Company: BDI - BioEnergy International AG Parkring 18 A-8074 Grambach/Graz Austria Phone: +43 - 316 - 4009-100 Fax: +43 - 316 - 4009-110 E-mail: bdi@bdi-bioenergy.com Internet: www.bdi-bioenergy.com ISIN: AT0000A02177 WKN: A0LAXT Listed: Regulated Market in Frankfurt (General Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Munich, Stuttgart End of News DGAP News Service ---------------------------------------------------------------------------
519729 11.11.2016
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu BDI - BioEnergy International AGmehr Nachrichten
| Keine Nachrichten verfügbar. |
Analysen zu BDI - BioEnergy International AGmehr Analysen
Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.